Tag: ResMed
Resmed discontinues Astral ventilator portfolio
October 19, 2026HME News Staff
SAN DIEGO – Resmed discontinued new sales of its Astral ventilator portfolio effective Sept. 14, 2026, according to a letter to customers.
The company says the decision allows it to prioritize available components and resources toward existing patients and continuity of care, following a field safety corrective action (FSCA).
“Ongoing supply constraints affecting critical electronic components have created significant challenges for the continued manufacture of Astral ventilators,”...
Eight Sleep, Resmed partner to increase understanding of sleep health
October 19, 2026HME News Staff
NEW YORK and SAN DIEGO – A new partnership will bridge technology from Eight Sleep with sleep insights from Resmed, helping people in the United States and Australia better understand their sleep health, the companies say.
As part of the collaboration, Resmed has also made an investment in Eight Sleep.
“At Eight Sleep, we’re focused on transforming the bed and bedroom into a preventative and predictive health platform,” said Matteo Franceschetti, co-founder and CEO of...
In brief: Resmed’s discontinuation, Samsung’s accuracy, RPM’s impact
October 16, 2026HME News Staff
SAN DIEGO – Resmed discontinued new sales of its Astral ventilator portfolio effective Sept. 14, 2026, according to a letter to customers.
The company says the decision allows it to prioritize available components and resources toward existing patients and continuity of care, following a field safety corrective action (FSCA).
“Ongoing supply constraints affecting critical electronic components have created significant challenges for the continued manufacture of Astral ventilators,”...
Resmed signs NASCAR racer in new collab to raise awareness of sleep apnea
September 1, 2026HME News Staff
SAN DIEGO – Resmed has a new collaboration with 23XI Racing and its NASCAR Cup Series driver Tyler Reddick to encourage more people to recognize the signs of sleep apnea and seek diagnosis and treatment. After being diagnosed with obstructive sleep apnea (OSA) and starting continuous positive airway pressure (CPAP) therapy in early 2026, Reddick went on to become the first driver in NASCAR Cup Series history to open a season with three consecutive victories, which included the Daytona...
In brief: McKesson breach, Daybreak-Parachute partnership, Resmed sponsorship
August 28, 2026HME News Staff
IRVING, Texas – McKesson discovered a cybersecurity incident on Aug. 25 affecting its information systems, the company disclosed in a Form 8-K filed with the U.S. Securities and Exchange Commission (SEC).
Based on its investigation thus far, including assessments by leading cybersecurity industry experts, McKesson has confirmed that the unauthorized access to certain third-party applications and the exfiltration of certain data was associated with a subset of customers within its Oncology...
Resmed board set to get new lead director
August 18, 2026HME News Staff
SAN DIEGO – Resmed has announced that Carol Burt will become lead director on Nov. 15, 2026, succeeding Ron Taylor, who is not standing for re-election at the company’s 2026 Annual Meeting of Stockholders on Nov. 18 and will retire after more than 21 years of service to the company. Burt has served on Resmed’s board since 2013 and currently chairs the Nominating and Governance Committee. She is also a member of the Audit Committee and the Compliance, Privacy and Quality Committee....
Resmed looks to customers to ‘share the load’ of inflation
August 7, 2026Liz Beaulieu, Editor
SAN DIEGO – Resmed officials say the company will implement what they call "modest price increases" as inflationary pressures continue to affect its business globally.
During the company's fourth-quarter earnings call, CEO Mick Farrell said Resmed has worked to offset higher costs through productivity gains and operational efficiencies, but inflation has reached a point where additional measures are necessary.
"I can tell you, look, nobody is immune to the global inflation...
Resmed reports double-digit increase in revenue for full year 2026
August 6, 2026HME News Staff
SAN DIEGO – Resmed reported revenue of $1.5 billion for the fourth quarter of fiscal year 2026, a 9% increase, and $5.7 billion for the full year, a 10% increase.
“We closed fiscal year 2026 with strong fourth quarter results, reflecting continued momentum of our global business, sustained demand for our market-leading products, and disciplined execution of our strategy,” said Chairman and CEO Mick Farrell. “Year-over-year, we delivered 9% reported revenue growth, 90 basis...
FDA updates early alert for Resmed vents
August 5, 2026HME News Staff
WASHINGTON – The U.S. Food and Drug Administration (FDA) has updated its early alert for certain Resmed Astral ventilators to a recall. “The affected products and recommendations for what to do with the devices have not changed,” the agency stated. “This recall involves correcting certain devices and does not involve removing them from where they are used or sold.” The FDA has identified the recall as the most serious type, with the potential to cause serious injury...
UPDATED: FDA issues early alert of potential issue with Resmed Astral
July 16, 2026HME News Staff
WASHINGTON - The U.S. Food and Drug Administration (FDA) on July 15 issued an early alert to notify the public of a potentially high-risk device issue with certain Resmed Astral 100 and Astral 150 ventilators.
The FDA said it is aware that Resmed has issued a voluntary Global Medical Device Correction / Field Safety Notice for its Astral 100 and Astral 150 ventilators built prior to October 2024 due to the potential of a component called a supercapacitor leaking over time. The leakage...